AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Insider Transactions Reported | Hims & Hers Health(HIMS)saw insider trading activity on 7/25/2025
ByAinvest
Saturday, Jul 26, 2025 12:00 am ET1min read
Hims & Hers Health(HIMS) saw insider trading activity on 7/25/2025, there were 6 insider trades during the day.
【History Insider Transaction】
| Declare date | Position | Name | Buy/Sell | Quantity | Price per share/USD | Total Amount/USD |
|---|---|---|---|---|---|---|
| 7/25/2025 | Chief Commercial Officer | Chi Michael | Buy | 900 | 6.82 | 6.14k |
| 7/25/2025 | Chief Commercial Officer | Chi Michael | Buy | 14700 | 5.01 | 73.65k |
| 7/25/2025 | Chief Commercial Officer | Chi Michael | Sell | 13750 | 56.00 | 770.0k |
| 7/25/2025 | Chief Commercial Officer | Chi Michael | Sell | 2100 | 57.52 | 120.79k |
| 7/25/2025 | Chief Commercial Officer | Chi Michael | Buy | 250 | 11.53 | 2.88k |
| 7/23/2025 | Chief Executive Officer | Dudum Andrew | Sell | 41667 | 49.56 | 2064.85k |
| 7/23/2025 | Chief Executive Officer | Dudum Andrew | Sell | 50000 | 49.60 | 2479.94k |
| 7/23/2025 | Chief Executive Officer | Dudum Andrew | Buy | 125335 | 2.43 | 304.56k |
| 7/23/2025 | Chief Executive Officer | Dudum Andrew | Sell | 17001 | 49.43 | 840.28k |
| 7/23/2025 | Chief Executive Officer | Dudum Andrew | Sell | 16667 | 49.41 | 823.58k |
[Company Profile]
Hims & Hers Health, Inc. was established as a Delaware company on December 30, 2013. Their mission is to enable everyone to enjoy affordable and convenient healthcare. They designed and built cloud-based digital native technology with consumers as the center, and considered consumers in the design. Their proprietary website, telemedicine platform, electronic medical record system, pharmacy integration and mobile accessibility combine to provide consumers with a seamless, easy-to-use, mobile-first experience.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet